MX356258B - Agente de contraste para obtener imágenes de la perfusión miocárdica. - Google Patents
Agente de contraste para obtener imágenes de la perfusión miocárdica.Info
- Publication number
- MX356258B MX356258B MX2014007491A MX2014007491A MX356258B MX 356258 B MX356258 B MX 356258B MX 2014007491 A MX2014007491 A MX 2014007491A MX 2014007491 A MX2014007491 A MX 2014007491A MX 356258 B MX356258 B MX 356258B
- Authority
- MX
- Mexico
- Prior art keywords
- myocardial perfusion
- imagining
- contrast agent
- linked
- imaging
- Prior art date
Links
- 230000002107 myocardial effect Effects 0.000 title abstract 2
- 230000010412 perfusion Effects 0.000 title abstract 2
- 239000002872 contrast media Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 238000003384 imaging method Methods 0.000 abstract 3
- 238000002059 diagnostic imaging Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002243 precursor Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161579113P | 2011-12-22 | 2011-12-22 | |
| SE1151249 | 2011-12-22 | ||
| PCT/SE2012/051421 WO2013095273A1 (en) | 2011-12-22 | 2012-12-18 | Contrast agent for imagining myocardial perfusion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014007491A MX2014007491A (es) | 2015-02-17 |
| MX356258B true MX356258B (es) | 2018-05-16 |
Family
ID=48668967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014007491A MX356258B (es) | 2011-12-22 | 2012-12-18 | Agente de contraste para obtener imágenes de la perfusión miocárdica. |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US9295738B2 (enExample) |
| EP (1) | EP2793952B1 (enExample) |
| JP (1) | JP6140187B2 (enExample) |
| KR (1) | KR101931792B1 (enExample) |
| CN (1) | CN104114191A (enExample) |
| AU (1) | AU2012354223B2 (enExample) |
| BR (1) | BR112014015124A2 (enExample) |
| CA (1) | CA2859773C (enExample) |
| ES (1) | ES2687234T3 (enExample) |
| IL (1) | IL233219A (enExample) |
| MX (1) | MX356258B (enExample) |
| RU (1) | RU2629840C2 (enExample) |
| SG (1) | SG11201403429YA (enExample) |
| WO (1) | WO2013095273A1 (enExample) |
| ZA (1) | ZA201405199B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9955876B2 (en) * | 2016-09-08 | 2018-05-01 | Raul Chirife | Device and method for assessment of left ventricular ejection fraction and other parameters of cardiac performance |
| CN107233585B (zh) * | 2017-06-09 | 2021-01-22 | 四川大学华西医院 | 黄连素或其衍生物在制备心肌灌注显像剂中的用途 |
| CN114832118B (zh) * | 2022-07-04 | 2022-09-27 | 北京先通国际医药科技股份有限公司 | 化合物i液体组合物、制备方法及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7344702B2 (en) | 2004-02-13 | 2008-03-18 | Bristol-Myers Squibb Pharma Company | Contrast agents for myocardial perfusion imaging |
| US7932272B2 (en) | 2003-09-30 | 2011-04-26 | Eisai R&D Management Co., Ltd. | Antifungal agent containing heterocyclic compound |
| US7824659B2 (en) * | 2005-08-10 | 2010-11-02 | Lantheus Medical Imaging, Inc. | Methods of making radiolabeled tracers and precursors thereof |
| WO2010097410A1 (en) | 2009-02-24 | 2010-09-02 | Respiratorius Ab | Novel bronchodilating diazaheteroaryls |
-
2012
- 2012-12-18 US US14/367,520 patent/US9295738B2/en not_active Expired - Fee Related
- 2012-12-18 CA CA2859773A patent/CA2859773C/en active Active
- 2012-12-18 EP EP12858896.9A patent/EP2793952B1/en not_active Not-in-force
- 2012-12-18 WO PCT/SE2012/051421 patent/WO2013095273A1/en not_active Ceased
- 2012-12-18 JP JP2014548735A patent/JP6140187B2/ja not_active Expired - Fee Related
- 2012-12-18 KR KR1020147018989A patent/KR101931792B1/ko not_active Expired - Fee Related
- 2012-12-18 AU AU2012354223A patent/AU2012354223B2/en not_active Ceased
- 2012-12-18 SG SG11201403429YA patent/SG11201403429YA/en unknown
- 2012-12-18 ES ES12858896.9T patent/ES2687234T3/es active Active
- 2012-12-18 CN CN201280069796.5A patent/CN104114191A/zh active Pending
- 2012-12-18 RU RU2014125849A patent/RU2629840C2/ru active
- 2012-12-18 BR BR112014015124A patent/BR112014015124A2/pt not_active Application Discontinuation
- 2012-12-18 MX MX2014007491A patent/MX356258B/es active IP Right Grant
-
2014
- 2014-06-18 IL IL233219A patent/IL233219A/en active IP Right Grant
- 2014-07-16 ZA ZA2014/05199A patent/ZA201405199B/en unknown
-
2015
- 2015-12-17 US US14/972,127 patent/US9687565B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20160101195A1 (en) | 2016-04-14 |
| ZA201405199B (en) | 2015-12-23 |
| KR20140107411A (ko) | 2014-09-04 |
| EP2793952A1 (en) | 2014-10-29 |
| RU2014125849A (ru) | 2016-02-10 |
| IL233219A (en) | 2016-08-31 |
| HK1201459A1 (en) | 2015-09-04 |
| EP2793952B1 (en) | 2018-06-13 |
| WO2013095273A1 (en) | 2013-06-27 |
| CA2859773A1 (en) | 2013-06-27 |
| SG11201403429YA (en) | 2014-07-30 |
| AU2012354223A1 (en) | 2014-07-03 |
| US9687565B2 (en) | 2017-06-27 |
| US9295738B2 (en) | 2016-03-29 |
| MX2014007491A (es) | 2015-02-17 |
| AU2012354223B2 (en) | 2017-03-16 |
| US20140341808A1 (en) | 2014-11-20 |
| IL233219A0 (en) | 2014-08-31 |
| ES2687234T3 (es) | 2018-10-24 |
| KR101931792B1 (ko) | 2019-03-13 |
| JP2015500873A (ja) | 2015-01-08 |
| CA2859773C (en) | 2020-09-01 |
| BR112014015124A2 (pt) | 2017-06-13 |
| EP2793952A4 (en) | 2015-09-09 |
| CN104114191A (zh) | 2014-10-22 |
| JP6140187B2 (ja) | 2017-05-31 |
| RU2629840C2 (ru) | 2017-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR201904041T4 (tr) | Protein agregasyonu ile bağlantılı hastalıklarda ve/veya nörodejeneratif hastalıklarda rol oynayan proteinlerin agregasyonunu inhibe etmeye yönelik ilaçlar. | |
| WO2009110984A3 (en) | Contrast agents for applications including perfusion imaging | |
| GEP20237479B (en) | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer | |
| NZ590923A (en) | Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment | |
| NO20064011L (no) | Kontrastmidler for myokardial perfusjonsbilleddannelse | |
| TR201910084T4 (tr) | Radyoaktif-etiketli prostat spesifik membran antijen inhibitörleri. | |
| EA201491362A1 (ru) | Анестезирующие соединения и способы их применения | |
| EA201170198A1 (ru) | Фармацевтические композиции, содержащие лиганды рецептора дофамина | |
| BR112016010080A8 (pt) | compostos de pirazolopirimidina, composição farmacêutica e seu uso | |
| EA201590979A1 (ru) | Способы и промежуточные химические соединения для получения фармацевтических средств | |
| HRP20090235B1 (hr) | Karbonilirani (aza) cikloheksani kao ligandi dopaminskog receptora d | |
| MX2014001595A (es) | Compuestos de imidazol, composiciones y metodos de uso. | |
| TN2012000152A1 (en) | Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes | |
| MY183312A (en) | Pharmaceutical formulation | |
| MX352546B (es) | Compuesto para la union de glicoproteina iib/iiia especifica a plaquetas y su uso para la formacion de imagenes de un trombo. | |
| TN2013000413A1 (en) | Glycoside derivatives and their uses for the treatment of diabetes | |
| PH12015500252A1 (en) | Niclosamide for the treatment of solid tumors | |
| RU2012148909A (ru) | Новый синтез соединений тиазолидиндиона | |
| EP3404029A3 (en) | Pyrimido-pyridazinone compounds and methods and use thereof | |
| MX372721B (es) | Ánalogos halogenados de agentes antifi-broticos. | |
| EA201391524A1 (ru) | Производные гликозида и их применение | |
| MX2014007491A (es) | Agente de contraste para obtener imagenes de la perfusion miocardica. | |
| JP2011515406A5 (enExample) | ||
| WO2012151464A3 (en) | Use of radiographic contrast agents for detecting dental caries | |
| PH12013501017A1 (en) | Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |